SlideShare una empresa de Scribd logo
1 de 8
INTRODUCTION:
Diabetes mellitus is a condition in which the pancreas no longer produces enough insulin or cells stop
responding to the insulin that is produced, so that glucose in the blood cannot be absorbed into the cells
of the body. Symptoms include frequent urination, lethargy, excessive thirst, and hunger. The treatment
includes changes in diet, oral medications, and in some cases, daily injections of insulin.
The most common form of diabetes is Type II, It is sometimes called age-onset or adult-onset diabetes,
and this form of diabetes occurs most often in people who are overweight and who do not exercise.
Type II is considered a milder form of diabetes because of its slow onset (sometimes developing over the
course of several years) and because it usually can be controlled with diet and oral medication. The
consequences of uncontrolled and untreated Type II diabetes, however, are the just as serious as those
for Type I. This form is also called noninsulin-dependent diabetes, a term that is somewhat misleading.
Many people with Type II diabetes can control the condition with diet and oral medications, however,
insulin injections are sometimes necessary if treatment with diet and oral medication is not working.
The causes of diabetes mellitus are unclear, however, there seem to be both hereditary (genetic factors
passed on in families) and environmental factors involved. Research has shown that some people who
develop diabetes have common genetic markers. In Type I diabetes, the immune system, the body’s
defense system against infection, is believed to be triggered by a virus or another microorganism that
destroys cells in the pancreas that produce insulin. In Type II diabetes, age, obesity, and family history of
diabetes play a role.
In Type II diabetes, the pancreas may produce enough insulin, however, cells have become resistant to
the insulin produced and it may not work as effectively. Symptoms of Type II diabetes can begin so
gradually that a person may not know that he or she has it. Early signs are lethargy, extreme thirst, and
frequent urination. Other symptoms may include sudden weight loss, slow wound healing, urinary tract
infections, gum disease, or blurred vision. It is not unusual for Type II diabetes to be detected while a
patient is seeing a doctor about another health concern that is actually being caused by the yet
undiagnosed diabetes.
Individuals who are at high risk of developing Type II diabetes mellitus include people who:
are obese (more than 20% above their ideal body weight)
have a relative with diabetes mellitus
belong to a high-risk ethnic population (African-American, Native American, Hispanic, or Native
Hawaiian)
have been diagnosed with gestational diabetes or have delivered a baby weighing more than 9 lbs (4 kg)
have high blood pressure (140/90 mmHg or above)
have a high density lipoprotein cholesterol level less than or equal to 35 mg/dL and/or a triglyceride
level greater than or equal to 250 mg/dL
have had impaired glucose tolerance or impaired fasting glucose on previous testing
Diabetes mellitus is a common chronic disease requiring lifelong behavioral and lifestyle changes. It is
best managed with a team approach to empower the client to successfully manage the disease. As part
of the team the, the nurse plans, organizes, and coordinates care among the various health disciplines
involved; provides care and education and promotes the client’s health and well being. Diabetes is a
major public health worldwide. Its complications cause many devastating health problems.
ANATOMY AND PHYSIOLOGY:
Every cell in the human body needs energy in order to function. The body’s primary energy source is
glucose, a simple sugar resulting from the digestion of foods containing carbohydrates (sugars and
starches). Glucose from the digested food circulates in the blood as a ready energy source for any cells
that need it. Insulin is a hormone or chemical produced by cells in the pancreas, an organ located behind
the stomach. Insulin bonds to a receptor site on the outside of cell and acts like a key to open a doorway
into the cell through which glucose can enter. Some of the glucose can be converted to concentrated
energy sources like glycogen or fatty acids and saved for later use. When there is not enough insulin
produced or when the doorway no longer recognizes the insulin key, glucose stays in the blood rather
entering the cells.
PATHOPHYSIOLOGY:
DIAGNOSTIC TEST:
Several blood tests are used to measure blood glucose levels, the primary test for diagnosing diabetes.
Additional tests can determine the type of diabetes and its severity.
Random blood glucose test — for a random blood glucose test, blood can be drawn at any time
throughout the day, regardless of when the person last ate. A random blood glucose level of 200 mg/dL
(11.1 mmol/L) or higher in persons who have symptoms of high blood glucose (see “Symptoms” above)
suggests a diagnosis of diabetes.
Fasting blood glucose test — fasting blood glucose testing involves measuring blood glucose after not
eating or drinking for 8 to 12 hours (usually overnight). A normal fasting blood glucose level is less than
100 mg/dL. A fasting blood glucose of 126 mg/dL (7.0 mmol/L) or higher indicates diabetes. The test is
done by taking a small sample of blood from a vein or fingertip. It must be repeated on another day to
confirm that it remains abnormally high (see “Criteria for diagnosis” below).
Hemoglobin A1C test (A1C) — The A1C blood test measures the average blood glucose level during the
past two to three months. It is used to monitor blood glucose control in people with known diabetes,
but is not normally used to diagnose diabetes. Normal values for A1C are 4 to 6 percent (show figure 3).
The test is done by taking a small sample of blood from a vein or fingertip.
Oral glucose tolerance test — Oral glucose tolerance testing (OGTT) is the most sensitive test for
diagnosing diabetes and pre-diabetes. However, the OGTT is not routinely recommended because it is
inconvenient compared to a fasting blood glucose test.
The standard OGTT includes a fasting blood glucose test. The person then drinks a 75 gram liquid
glucose solution (which tastes very sweet, and is usually cola or orange-flavored). Two hours later, a
second blood glucose level is measured.
Oral glucose tolerance testing is routinely performed at 24 to 28 weeks of pregnancy to screen for
gestational diabetes; this requires drinking a 50 gram glucose solution with a blood glucose level drawn
one hour later. For women who have an abnormally elevated blood glucose level, a second OGTT is
performed on another day after drinking a 100 gram glucose solution. The blood glucose level is
measured before, and at one, two, and three hours after drinking the solution.
MEDICATIONS:
When diet, exercise and maintaining a healthy weight aren’t enough, you may need the help of
medication. Medications used to treat diabetes include insulin. Everyone with type 1 diabetes and some
people with type 2 diabetes must take insulin every day to replace what their pancreas is unable to
produce. Unfortunately, insulin can’t be taken in pill form because enzymes in your stomach break it
down so that it becomes ineffective. For that reason, many people inject themselves with insulin using a
syringe or an insulin pen injector,a device that looks like a pen, except the cartridge is filled with insulin.
Others may use an insulin pump, which provides a continuous supply of insulin, eliminating the need for
daily shots.
The most widely used form of insulin is synthetic human insulin, which is chemically identical to human
insulin but manufactured in a laboratory. Unfortunately, synthetic human insulin isn’t perfect. One of its
chief failings is that it doesn’t mimic the way natural insulin is secreted. But newer types of insulin,
known as insulin analogs, more closely resemble the way natural insulin acts in your body. Among these
are lispro (Humalog), insulin aspart (NovoLog) and glargine (Lantus).
A number of drug options exist for treating type 2 diabetes, including:
· Sulfonylurea drugs. These medications stimulate your pancreas to produce and release more insulin.
For them to be effective, your pancreas must produce some insulin on its own. Second-generation
sulfonylureas such as glipizide (Glucotrol, Glucotrol XL), glyburide (DiaBeta, Glynase PresTab, Micronase)
and glimepiride (Amaryl) are prescribed most often. The most common side effect of sulfonylureas is
low blood sugar, especially during the first four months of therapy. You’re at much greater risk of low
blood sugar if you have impaired liver or kidney function.
· Meglitinides. These medications, such as repaglinide (Prandin), have effects similar to sulfonylureas,
but you’re not as likely to develop low blood sugar. Meglitinides work quickly, and the results fade
rapidly.
· Biguanides. Metformin (Glucophage, Glucophage XR) is the only drug in this class available in the
United States. It works by inhibiting the production and release of glucose from your liver, which means
you need less insulin to transport blood sugar into your cells. One advantage of metformin is that is
tends to cause less weight gain than do other diabetes medications. Possible side effects include a
metallic taste in your mouth, loss of appetite, nausea or vomiting, abdominal bloating, or pain, gas and
diarrhea. These effects usually decrease over time and are less likely to occur if you take the medication
with food. A rare but serious side effect is lactic acidosis, which results when lactic acid builds up in your
body. Symptoms include tiredness, weakness, muscle aches, dizziness and drowsiness. Lactic acidosis is
especially likely to occur if you mix this medication with alcohol or have impaired kidney function.
· Alpha-glucosidase inhibitors. These drugs block the action of enzymes in your digestive tract that break
down carbohydrates. That means sugar is absorbed into your bloodstream more slowly, which helps
prevent the rapid rise in blood sugar that usually occurs right after a meal. Drugs in this class include
acarbose (Precose) and miglitol (Glyset). Although safe and effective, alpha-glucosidase inhibitors can
cause abdominal bloating, gas and diarrhea. If taken in high doses, they may also cause reversible liver
damage.
· Thiazolidinediones. These drugs make your body tissues more sensitive to insulin and keep your liver
from overproducing glucose. Side effects of thiazolidinediones, such as rosiglitazone (Avandia) and
pioglitazone hydrochloride (Actos), include swelling, weight gain and fatigue. A far more serious
potential side effect is liver damage. The thiazolidinedione troglitzeone (Rezulin) was taken off the
market in March 2000 because it caused liver failure. If your doctor prescribes these drugs, it’s
important to have your liver checked every two months during the first year of therapy. Contact your
doctor immediately if you experience any of the signs and symptoms of liver damage, such as nausea
and vomiting, abdominal pain, loss of appetite, dark urine, or yellowing of your skin and the whites of
your eyes (jaundice). These may not always be related to diabetes medications, but your doctor will
need to investigate all possible causes.
· Drug combinations. By combining drugs from different classes, you may be able to control your blood
sugar in several different ways. Each class of oral medication can be combined with drugs from any
other class. Most doctors prescribe two drugs in combination, although sometimes three drugs may be
prescribed. Newer medications, such as Glucovance, which contains both glyburide and metformin,
combine different oral drugs in a single tablet.
NURSING INTERVENTIONS:
Advice patient about the importance of an individualized meal plan in meeting weekly weight loss goals
and assist with compliance.
Assess patients for cognitive or sensory impairments, which may interfere with the ability to accurately
administer insulin.
Demonstrate and explain thoroughly the procedure for insulin self-injection. Help patient to achieve
mastery of technique by taking step by step approach.
Review dosage and time of injections in relation to meals, activity, and bedtime based on patients
individualized insulin regimen.
Instruct patient in the importance of accuracy of insulin preparation and meal timing to avoid
hypoglycemia.
Explain the importance of exercise in maintaining or reducing weight.
Advise patient to assess blood glucose level before strenuous activity and to eat carbohydrate snack
before exercising to avoid hypoglycemia.
Assess feet and legs for skin temperature, sensation, soft tissues injuries, corns, calluses, dryness, hair
distribution, pulses and deep tendon reflexes.
Maintain skin integrity by protecting feet from breakdown.
Advice patient who smokes to stop smoking or reduce if possible, to reduce vasoconstriction and
enhance peripheral flow.

Más contenido relacionado

La actualidad más candente

La actualidad más candente (18)

Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Diabetes presentation
Diabetes presentationDiabetes presentation
Diabetes presentation
 
Type 1 Diabetes(1)
Type 1 Diabetes(1)Type 1 Diabetes(1)
Type 1 Diabetes(1)
 
Diabetes Mellitus and its types
Diabetes Mellitus and its types Diabetes Mellitus and its types
Diabetes Mellitus and its types
 
Diabetes (2) (1)
Diabetes (2) (1)Diabetes (2) (1)
Diabetes (2) (1)
 
Diabetes
Diabetes Diabetes
Diabetes
 
Guide to Diabetes
Guide to Diabetes Guide to Diabetes
Guide to Diabetes
 
Idf course module 2 overview of diabetes management
Idf course module 2 overview of diabetes managementIdf course module 2 overview of diabetes management
Idf course module 2 overview of diabetes management
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Day care management of diabetes mellitus in children
Day care management of diabetes mellitus in childrenDay care management of diabetes mellitus in children
Day care management of diabetes mellitus in children
 
Diabetes
Diabetes Diabetes
Diabetes
 
Dm
DmDm
Dm
 
Juvenile diabetes –type 1
Juvenile diabetes –type 1Juvenile diabetes –type 1
Juvenile diabetes –type 1
 
DIABETES MELLITUS an up-to-date 2017- 2018
DIABETES MELLITUS an up-to-date 2017- 2018DIABETES MELLITUS an up-to-date 2017- 2018
DIABETES MELLITUS an up-to-date 2017- 2018
 
CME Sohag | internal medicine | Diabetes mellitus
CME Sohag | internal medicine | Diabetes mellitusCME Sohag | internal medicine | Diabetes mellitus
CME Sohag | internal medicine | Diabetes mellitus
 
Diabetes
DiabetesDiabetes
Diabetes
 
2015-12-03 PAO: The Changing Landscape of Diabetes
2015-12-03 PAO: The Changing Landscape of Diabetes2015-12-03 PAO: The Changing Landscape of Diabetes
2015-12-03 PAO: The Changing Landscape of Diabetes
 

Destacado

Baking Mad SEO: Best UK SEO Campaign 2012
Baking Mad SEO: Best UK SEO Campaign 2012Baking Mad SEO: Best UK SEO Campaign 2012
Baking Mad SEO: Best UK SEO Campaign 2012Richard Kirk
 
12ο Δ.Σ. Νέας Σμύρνης Σ.Τ. - Γ3
12ο Δ.Σ. Νέας Σμύρνης   Σ.Τ. - Γ312ο Δ.Σ. Νέας Σμύρνης   Σ.Τ. - Γ3
12ο Δ.Σ. Νέας Σμύρνης Σ.Τ. - Γ3Andreas Androulakis
 
Francois Lelord-cum-sa-ne-purtam-cu-personalitatile-dificile-1
Francois Lelord-cum-sa-ne-purtam-cu-personalitatile-dificile-1Francois Lelord-cum-sa-ne-purtam-cu-personalitatile-dificile-1
Francois Lelord-cum-sa-ne-purtam-cu-personalitatile-dificile-1ioana0410
 
Non surgical management of large periapical radiolucency
Non surgical management of large periapical radiolucencyNon surgical management of large periapical radiolucency
Non surgical management of large periapical radiolucencyDr. Roshni Maurya
 
Summary Report: B4E Climate Summit 2014, London
Summary Report: B4E Climate Summit 2014, LondonSummary Report: B4E Climate Summit 2014, London
Summary Report: B4E Climate Summit 2014, LondonGlobal Initiatives
 
Putivnyk 2009 04_14
Putivnyk 2009 04_14Putivnyk 2009 04_14
Putivnyk 2009 04_14Ann Dardalan
 
Senior Expedition Introduction
Senior Expedition IntroductionSenior Expedition Introduction
Senior Expedition IntroductionRBHSLC
 
Instrumento y unidad de medida
Instrumento y unidad de medidaInstrumento y unidad de medida
Instrumento y unidad de medidaviancaa
 
Outcome Statement: B4E Climate Summit 2011, London
Outcome Statement: B4E Climate Summit 2011, LondonOutcome Statement: B4E Climate Summit 2011, London
Outcome Statement: B4E Climate Summit 2011, LondonGlobal Initiatives
 
ματωμενα χωματα
ματωμενα χωματαματωμενα χωματα
ματωμενα χωματαharitinitrigazi1
 
Ravikumar _Resume
Ravikumar _ResumeRavikumar _Resume
Ravikumar _ResumeRavi kumar
 

Destacado (17)

Baking Mad SEO: Best UK SEO Campaign 2012
Baking Mad SEO: Best UK SEO Campaign 2012Baking Mad SEO: Best UK SEO Campaign 2012
Baking Mad SEO: Best UK SEO Campaign 2012
 
12ο Δ.Σ. Νέας Σμύρνης Σ.Τ. - Γ3
12ο Δ.Σ. Νέας Σμύρνης   Σ.Τ. - Γ312ο Δ.Σ. Νέας Σμύρνης   Σ.Τ. - Γ3
12ο Δ.Σ. Νέας Σμύρνης Σ.Τ. - Γ3
 
Francois Lelord-cum-sa-ne-purtam-cu-personalitatile-dificile-1
Francois Lelord-cum-sa-ne-purtam-cu-personalitatile-dificile-1Francois Lelord-cum-sa-ne-purtam-cu-personalitatile-dificile-1
Francois Lelord-cum-sa-ne-purtam-cu-personalitatile-dificile-1
 
Non surgical management of large periapical radiolucency
Non surgical management of large periapical radiolucencyNon surgical management of large periapical radiolucency
Non surgical management of large periapical radiolucency
 
Summary Report: B4E Climate Summit 2014, London
Summary Report: B4E Climate Summit 2014, LondonSummary Report: B4E Climate Summit 2014, London
Summary Report: B4E Climate Summit 2014, London
 
Putivnyk 2009 04_14
Putivnyk 2009 04_14Putivnyk 2009 04_14
Putivnyk 2009 04_14
 
Super-Brochure2
Super-Brochure2Super-Brochure2
Super-Brochure2
 
Senior Expedition Introduction
Senior Expedition IntroductionSenior Expedition Introduction
Senior Expedition Introduction
 
Comprometidos con la inclusion y la vida
Comprometidos con la inclusion y la vidaComprometidos con la inclusion y la vida
Comprometidos con la inclusion y la vida
 
Instrumento y unidad de medida
Instrumento y unidad de medidaInstrumento y unidad de medida
Instrumento y unidad de medida
 
Outcome Statement: B4E Climate Summit 2011, London
Outcome Statement: B4E Climate Summit 2011, LondonOutcome Statement: B4E Climate Summit 2011, London
Outcome Statement: B4E Climate Summit 2011, London
 
Cómo promover, ideas para los diocesanos
Cómo promover,  ideas para los diocesanosCómo promover,  ideas para los diocesanos
Cómo promover, ideas para los diocesanos
 
Ilustracion
IlustracionIlustracion
Ilustracion
 
Jsp & struts
Jsp & strutsJsp & struts
Jsp & struts
 
το ψεμα
το ψεματο ψεμα
το ψεμα
 
ματωμενα χωματα
ματωμενα χωματαματωμενα χωματα
ματωμενα χωματα
 
Ravikumar _Resume
Ravikumar _ResumeRavikumar _Resume
Ravikumar _Resume
 

Similar a 59859165 case-study

diabetes word document
diabetes word document diabetes word document
diabetes word document kavyayadav28
 
DIABETES MLLITUS 2.pptx
DIABETES MLLITUS 2.pptxDIABETES MLLITUS 2.pptx
DIABETES MLLITUS 2.pptxShanzaAwan3
 
You can live with diabetes if you learn how! diabetes treatment
You can live with diabetes if you learn how! diabetes treatmentYou can live with diabetes if you learn how! diabetes treatment
You can live with diabetes if you learn how! diabetes treatmentasucoms
 
Diabetes mellitus with complication
Diabetes mellitus with complicationDiabetes mellitus with complication
Diabetes mellitus with complicationDipali Dumbre
 
Everything About Diabetes
Everything About DiabetesEverything About Diabetes
Everything About DiabetesArbab Usmani
 
Diabetes. Presented by Theresa Lowry-Lehnen. Nurse Practitioner and Lecturer.
Diabetes. Presented by Theresa Lowry-Lehnen. Nurse Practitioner and Lecturer.Diabetes. Presented by Theresa Lowry-Lehnen. Nurse Practitioner and Lecturer.
Diabetes. Presented by Theresa Lowry-Lehnen. Nurse Practitioner and Lecturer.Theresa Lowry-Lehnen
 
What Causes Diabetes? The Possible Reasons
What Causes Diabetes? The Possible ReasonsWhat Causes Diabetes? The Possible Reasons
What Causes Diabetes? The Possible Reasonskittycolbert7
 
What you need to know about Diabetes Mellitus
What you need to know about Diabetes MellitusWhat you need to know about Diabetes Mellitus
What you need to know about Diabetes MellitusFAMAKINWAPRECIOUS
 
Diabetes thebasics
Diabetes thebasicsDiabetes thebasics
Diabetes thebasicsShahid Nawaz
 
Learn to Control Your Diabetes Effectively
Learn to Control Your Diabetes EffectivelyLearn to Control Your Diabetes Effectively
Learn to Control Your Diabetes Effectivelydocblogger
 

Similar a 59859165 case-study (20)

Diabetes presentation
Diabetes presentationDiabetes presentation
Diabetes presentation
 
Diabetes presentation
Diabetes presentationDiabetes presentation
Diabetes presentation
 
diabetes word document
diabetes word document diabetes word document
diabetes word document
 
Diabetes
Diabetes Diabetes
Diabetes
 
DIABETES MLLITUS 2.pptx
DIABETES MLLITUS 2.pptxDIABETES MLLITUS 2.pptx
DIABETES MLLITUS 2.pptx
 
You can live with diabetes if you learn how! diabetes treatment
You can live with diabetes if you learn how! diabetes treatmentYou can live with diabetes if you learn how! diabetes treatment
You can live with diabetes if you learn how! diabetes treatment
 
Diabetes
DiabetesDiabetes
Diabetes
 
diabetes food pyramid.ppt
diabetes food pyramid.pptdiabetes food pyramid.ppt
diabetes food pyramid.ppt
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes mellitus with complication
Diabetes mellitus with complicationDiabetes mellitus with complication
Diabetes mellitus with complication
 
Everything About Diabetes
Everything About DiabetesEverything About Diabetes
Everything About Diabetes
 
Diabetes. Presented by Theresa Lowry-Lehnen. Nurse Practitioner and Lecturer.
Diabetes. Presented by Theresa Lowry-Lehnen. Nurse Practitioner and Lecturer.Diabetes. Presented by Theresa Lowry-Lehnen. Nurse Practitioner and Lecturer.
Diabetes. Presented by Theresa Lowry-Lehnen. Nurse Practitioner and Lecturer.
 
Yoga for diabetes and obesity 2010
Yoga for diabetes and obesity 2010Yoga for diabetes and obesity 2010
Yoga for diabetes and obesity 2010
 
Diabetes 101 guide
Diabetes 101 guideDiabetes 101 guide
Diabetes 101 guide
 
What Causes Diabetes? The Possible Reasons
What Causes Diabetes? The Possible ReasonsWhat Causes Diabetes? The Possible Reasons
What Causes Diabetes? The Possible Reasons
 
What you need to know about Diabetes Mellitus
What you need to know about Diabetes MellitusWhat you need to know about Diabetes Mellitus
What you need to know about Diabetes Mellitus
 
Diabetes thebasics
Diabetes thebasicsDiabetes thebasics
Diabetes thebasics
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Learn to Control Your Diabetes Effectively
Learn to Control Your Diabetes EffectivelyLearn to Control Your Diabetes Effectively
Learn to Control Your Diabetes Effectively
 

Más de homeworkping4

242269855 dell-case-study
242269855 dell-case-study242269855 dell-case-study
242269855 dell-case-studyhomeworkping4
 
242266287 case-study-on-guil
242266287 case-study-on-guil242266287 case-study-on-guil
242266287 case-study-on-guilhomeworkping4
 
242259868 legal-research-cases
242259868 legal-research-cases242259868 legal-research-cases
242259868 legal-research-caseshomeworkping4
 
241999259 case-hemstoma-sukonjungtiva
241999259 case-hemstoma-sukonjungtiva241999259 case-hemstoma-sukonjungtiva
241999259 case-hemstoma-sukonjungtivahomeworkping4
 
241985748 plm-case-study
241985748 plm-case-study241985748 plm-case-study
241985748 plm-case-studyhomeworkping4
 
241946212 case-study-for-ocd
241946212 case-study-for-ocd241946212 case-study-for-ocd
241946212 case-study-for-ocdhomeworkping4
 
241941333 case-digest-statcon
241941333 case-digest-statcon241941333 case-digest-statcon
241941333 case-digest-statconhomeworkping4
 
241909563 impact-of-emergency
241909563 impact-of-emergency241909563 impact-of-emergency
241909563 impact-of-emergencyhomeworkping4
 
241905839 mpcvv-report
241905839 mpcvv-report241905839 mpcvv-report
241905839 mpcvv-reporthomeworkping4
 
241767629 ethics-cases
241767629 ethics-cases241767629 ethics-cases
241767629 ethics-caseshomeworkping4
 
241716493 separation-of-powers-cases
241716493 separation-of-powers-cases241716493 separation-of-powers-cases
241716493 separation-of-powers-caseshomeworkping4
 
241603963 drug-study-final
241603963 drug-study-final241603963 drug-study-final
241603963 drug-study-finalhomeworkping4
 
241573114 persons-cases
241573114 persons-cases241573114 persons-cases
241573114 persons-caseshomeworkping4
 
241566373 workshop-on-case-study
241566373 workshop-on-case-study241566373 workshop-on-case-study
241566373 workshop-on-case-studyhomeworkping4
 
241524597 succession-full-cases
241524597 succession-full-cases241524597 succession-full-cases
241524597 succession-full-caseshomeworkping4
 
241299249 pale-cases-batch-2
241299249 pale-cases-batch-2241299249 pale-cases-batch-2
241299249 pale-cases-batch-2homeworkping4
 
241262134 rubab-thesis
241262134 rubab-thesis241262134 rubab-thesis
241262134 rubab-thesishomeworkping4
 
241259161 citizenship-case-digests
241259161 citizenship-case-digests241259161 citizenship-case-digests
241259161 citizenship-case-digestshomeworkping4
 

Más de homeworkping4 (20)

242269855 dell-case-study
242269855 dell-case-study242269855 dell-case-study
242269855 dell-case-study
 
242266287 case-study-on-guil
242266287 case-study-on-guil242266287 case-study-on-guil
242266287 case-study-on-guil
 
242259868 legal-research-cases
242259868 legal-research-cases242259868 legal-research-cases
242259868 legal-research-cases
 
241999259 case-hemstoma-sukonjungtiva
241999259 case-hemstoma-sukonjungtiva241999259 case-hemstoma-sukonjungtiva
241999259 case-hemstoma-sukonjungtiva
 
241985748 plm-case-study
241985748 plm-case-study241985748 plm-case-study
241985748 plm-case-study
 
241946212 case-study-for-ocd
241946212 case-study-for-ocd241946212 case-study-for-ocd
241946212 case-study-for-ocd
 
241941333 case-digest-statcon
241941333 case-digest-statcon241941333 case-digest-statcon
241941333 case-digest-statcon
 
241909563 impact-of-emergency
241909563 impact-of-emergency241909563 impact-of-emergency
241909563 impact-of-emergency
 
241905839 mpcvv-report
241905839 mpcvv-report241905839 mpcvv-report
241905839 mpcvv-report
 
241767629 ethics-cases
241767629 ethics-cases241767629 ethics-cases
241767629 ethics-cases
 
241716493 separation-of-powers-cases
241716493 separation-of-powers-cases241716493 separation-of-powers-cases
241716493 separation-of-powers-cases
 
241603963 drug-study-final
241603963 drug-study-final241603963 drug-study-final
241603963 drug-study-final
 
241585426 cases-vii
241585426 cases-vii241585426 cases-vii
241585426 cases-vii
 
241573114 persons-cases
241573114 persons-cases241573114 persons-cases
241573114 persons-cases
 
241566373 workshop-on-case-study
241566373 workshop-on-case-study241566373 workshop-on-case-study
241566373 workshop-on-case-study
 
241524597 succession-full-cases
241524597 succession-full-cases241524597 succession-full-cases
241524597 succession-full-cases
 
241356684 citibank
241356684 citibank241356684 citibank
241356684 citibank
 
241299249 pale-cases-batch-2
241299249 pale-cases-batch-2241299249 pale-cases-batch-2
241299249 pale-cases-batch-2
 
241262134 rubab-thesis
241262134 rubab-thesis241262134 rubab-thesis
241262134 rubab-thesis
 
241259161 citizenship-case-digests
241259161 citizenship-case-digests241259161 citizenship-case-digests
241259161 citizenship-case-digests
 

Último

GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
TEACHER REFLECTION FORM (NEW SET........).docx
TEACHER REFLECTION FORM (NEW SET........).docxTEACHER REFLECTION FORM (NEW SET........).docx
TEACHER REFLECTION FORM (NEW SET........).docxruthvilladarez
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSMae Pangan
 
Presentation Activity 2. Unit 3 transv.pptx
Presentation Activity 2. Unit 3 transv.pptxPresentation Activity 2. Unit 3 transv.pptx
Presentation Activity 2. Unit 3 transv.pptxRosabel UA
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
EMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docxEMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docxElton John Embodo
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 

Último (20)

GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
TEACHER REFLECTION FORM (NEW SET........).docx
TEACHER REFLECTION FORM (NEW SET........).docxTEACHER REFLECTION FORM (NEW SET........).docx
TEACHER REFLECTION FORM (NEW SET........).docx
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHS
 
Presentation Activity 2. Unit 3 transv.pptx
Presentation Activity 2. Unit 3 transv.pptxPresentation Activity 2. Unit 3 transv.pptx
Presentation Activity 2. Unit 3 transv.pptx
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
EMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docxEMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docx
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptxFINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
FINALS_OF_LEFT_ON_C'N_EL_DORADO_2024.pptx
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 

59859165 case-study

  • 1. INTRODUCTION: Diabetes mellitus is a condition in which the pancreas no longer produces enough insulin or cells stop responding to the insulin that is produced, so that glucose in the blood cannot be absorbed into the cells of the body. Symptoms include frequent urination, lethargy, excessive thirst, and hunger. The treatment includes changes in diet, oral medications, and in some cases, daily injections of insulin. The most common form of diabetes is Type II, It is sometimes called age-onset or adult-onset diabetes, and this form of diabetes occurs most often in people who are overweight and who do not exercise. Type II is considered a milder form of diabetes because of its slow onset (sometimes developing over the course of several years) and because it usually can be controlled with diet and oral medication. The consequences of uncontrolled and untreated Type II diabetes, however, are the just as serious as those for Type I. This form is also called noninsulin-dependent diabetes, a term that is somewhat misleading. Many people with Type II diabetes can control the condition with diet and oral medications, however, insulin injections are sometimes necessary if treatment with diet and oral medication is not working. The causes of diabetes mellitus are unclear, however, there seem to be both hereditary (genetic factors passed on in families) and environmental factors involved. Research has shown that some people who develop diabetes have common genetic markers. In Type I diabetes, the immune system, the body’s defense system against infection, is believed to be triggered by a virus or another microorganism that destroys cells in the pancreas that produce insulin. In Type II diabetes, age, obesity, and family history of diabetes play a role. In Type II diabetes, the pancreas may produce enough insulin, however, cells have become resistant to the insulin produced and it may not work as effectively. Symptoms of Type II diabetes can begin so gradually that a person may not know that he or she has it. Early signs are lethargy, extreme thirst, and frequent urination. Other symptoms may include sudden weight loss, slow wound healing, urinary tract infections, gum disease, or blurred vision. It is not unusual for Type II diabetes to be detected while a patient is seeing a doctor about another health concern that is actually being caused by the yet undiagnosed diabetes.
  • 2. Individuals who are at high risk of developing Type II diabetes mellitus include people who: are obese (more than 20% above their ideal body weight) have a relative with diabetes mellitus belong to a high-risk ethnic population (African-American, Native American, Hispanic, or Native Hawaiian) have been diagnosed with gestational diabetes or have delivered a baby weighing more than 9 lbs (4 kg) have high blood pressure (140/90 mmHg or above) have a high density lipoprotein cholesterol level less than or equal to 35 mg/dL and/or a triglyceride level greater than or equal to 250 mg/dL have had impaired glucose tolerance or impaired fasting glucose on previous testing Diabetes mellitus is a common chronic disease requiring lifelong behavioral and lifestyle changes. It is best managed with a team approach to empower the client to successfully manage the disease. As part of the team the, the nurse plans, organizes, and coordinates care among the various health disciplines involved; provides care and education and promotes the client’s health and well being. Diabetes is a major public health worldwide. Its complications cause many devastating health problems. ANATOMY AND PHYSIOLOGY: Every cell in the human body needs energy in order to function. The body’s primary energy source is glucose, a simple sugar resulting from the digestion of foods containing carbohydrates (sugars and starches). Glucose from the digested food circulates in the blood as a ready energy source for any cells that need it. Insulin is a hormone or chemical produced by cells in the pancreas, an organ located behind the stomach. Insulin bonds to a receptor site on the outside of cell and acts like a key to open a doorway into the cell through which glucose can enter. Some of the glucose can be converted to concentrated energy sources like glycogen or fatty acids and saved for later use. When there is not enough insulin produced or when the doorway no longer recognizes the insulin key, glucose stays in the blood rather entering the cells.
  • 4. DIAGNOSTIC TEST: Several blood tests are used to measure blood glucose levels, the primary test for diagnosing diabetes. Additional tests can determine the type of diabetes and its severity. Random blood glucose test — for a random blood glucose test, blood can be drawn at any time throughout the day, regardless of when the person last ate. A random blood glucose level of 200 mg/dL (11.1 mmol/L) or higher in persons who have symptoms of high blood glucose (see “Symptoms” above) suggests a diagnosis of diabetes.
  • 5. Fasting blood glucose test — fasting blood glucose testing involves measuring blood glucose after not eating or drinking for 8 to 12 hours (usually overnight). A normal fasting blood glucose level is less than 100 mg/dL. A fasting blood glucose of 126 mg/dL (7.0 mmol/L) or higher indicates diabetes. The test is done by taking a small sample of blood from a vein or fingertip. It must be repeated on another day to confirm that it remains abnormally high (see “Criteria for diagnosis” below). Hemoglobin A1C test (A1C) — The A1C blood test measures the average blood glucose level during the past two to three months. It is used to monitor blood glucose control in people with known diabetes, but is not normally used to diagnose diabetes. Normal values for A1C are 4 to 6 percent (show figure 3). The test is done by taking a small sample of blood from a vein or fingertip. Oral glucose tolerance test — Oral glucose tolerance testing (OGTT) is the most sensitive test for diagnosing diabetes and pre-diabetes. However, the OGTT is not routinely recommended because it is inconvenient compared to a fasting blood glucose test. The standard OGTT includes a fasting blood glucose test. The person then drinks a 75 gram liquid glucose solution (which tastes very sweet, and is usually cola or orange-flavored). Two hours later, a second blood glucose level is measured. Oral glucose tolerance testing is routinely performed at 24 to 28 weeks of pregnancy to screen for gestational diabetes; this requires drinking a 50 gram glucose solution with a blood glucose level drawn one hour later. For women who have an abnormally elevated blood glucose level, a second OGTT is performed on another day after drinking a 100 gram glucose solution. The blood glucose level is measured before, and at one, two, and three hours after drinking the solution. MEDICATIONS: When diet, exercise and maintaining a healthy weight aren’t enough, you may need the help of medication. Medications used to treat diabetes include insulin. Everyone with type 1 diabetes and some people with type 2 diabetes must take insulin every day to replace what their pancreas is unable to produce. Unfortunately, insulin can’t be taken in pill form because enzymes in your stomach break it down so that it becomes ineffective. For that reason, many people inject themselves with insulin using a syringe or an insulin pen injector,a device that looks like a pen, except the cartridge is filled with insulin. Others may use an insulin pump, which provides a continuous supply of insulin, eliminating the need for daily shots.
  • 6. The most widely used form of insulin is synthetic human insulin, which is chemically identical to human insulin but manufactured in a laboratory. Unfortunately, synthetic human insulin isn’t perfect. One of its chief failings is that it doesn’t mimic the way natural insulin is secreted. But newer types of insulin, known as insulin analogs, more closely resemble the way natural insulin acts in your body. Among these are lispro (Humalog), insulin aspart (NovoLog) and glargine (Lantus). A number of drug options exist for treating type 2 diabetes, including: · Sulfonylurea drugs. These medications stimulate your pancreas to produce and release more insulin. For them to be effective, your pancreas must produce some insulin on its own. Second-generation sulfonylureas such as glipizide (Glucotrol, Glucotrol XL), glyburide (DiaBeta, Glynase PresTab, Micronase) and glimepiride (Amaryl) are prescribed most often. The most common side effect of sulfonylureas is low blood sugar, especially during the first four months of therapy. You’re at much greater risk of low blood sugar if you have impaired liver or kidney function. · Meglitinides. These medications, such as repaglinide (Prandin), have effects similar to sulfonylureas, but you’re not as likely to develop low blood sugar. Meglitinides work quickly, and the results fade rapidly. · Biguanides. Metformin (Glucophage, Glucophage XR) is the only drug in this class available in the United States. It works by inhibiting the production and release of glucose from your liver, which means you need less insulin to transport blood sugar into your cells. One advantage of metformin is that is tends to cause less weight gain than do other diabetes medications. Possible side effects include a metallic taste in your mouth, loss of appetite, nausea or vomiting, abdominal bloating, or pain, gas and diarrhea. These effects usually decrease over time and are less likely to occur if you take the medication with food. A rare but serious side effect is lactic acidosis, which results when lactic acid builds up in your body. Symptoms include tiredness, weakness, muscle aches, dizziness and drowsiness. Lactic acidosis is especially likely to occur if you mix this medication with alcohol or have impaired kidney function. · Alpha-glucosidase inhibitors. These drugs block the action of enzymes in your digestive tract that break down carbohydrates. That means sugar is absorbed into your bloodstream more slowly, which helps prevent the rapid rise in blood sugar that usually occurs right after a meal. Drugs in this class include acarbose (Precose) and miglitol (Glyset). Although safe and effective, alpha-glucosidase inhibitors can cause abdominal bloating, gas and diarrhea. If taken in high doses, they may also cause reversible liver damage.
  • 7. · Thiazolidinediones. These drugs make your body tissues more sensitive to insulin and keep your liver from overproducing glucose. Side effects of thiazolidinediones, such as rosiglitazone (Avandia) and pioglitazone hydrochloride (Actos), include swelling, weight gain and fatigue. A far more serious potential side effect is liver damage. The thiazolidinedione troglitzeone (Rezulin) was taken off the market in March 2000 because it caused liver failure. If your doctor prescribes these drugs, it’s important to have your liver checked every two months during the first year of therapy. Contact your doctor immediately if you experience any of the signs and symptoms of liver damage, such as nausea and vomiting, abdominal pain, loss of appetite, dark urine, or yellowing of your skin and the whites of your eyes (jaundice). These may not always be related to diabetes medications, but your doctor will need to investigate all possible causes. · Drug combinations. By combining drugs from different classes, you may be able to control your blood sugar in several different ways. Each class of oral medication can be combined with drugs from any other class. Most doctors prescribe two drugs in combination, although sometimes three drugs may be prescribed. Newer medications, such as Glucovance, which contains both glyburide and metformin, combine different oral drugs in a single tablet. NURSING INTERVENTIONS: Advice patient about the importance of an individualized meal plan in meeting weekly weight loss goals and assist with compliance. Assess patients for cognitive or sensory impairments, which may interfere with the ability to accurately administer insulin. Demonstrate and explain thoroughly the procedure for insulin self-injection. Help patient to achieve mastery of technique by taking step by step approach. Review dosage and time of injections in relation to meals, activity, and bedtime based on patients individualized insulin regimen. Instruct patient in the importance of accuracy of insulin preparation and meal timing to avoid hypoglycemia. Explain the importance of exercise in maintaining or reducing weight. Advise patient to assess blood glucose level before strenuous activity and to eat carbohydrate snack before exercising to avoid hypoglycemia.
  • 8. Assess feet and legs for skin temperature, sensation, soft tissues injuries, corns, calluses, dryness, hair distribution, pulses and deep tendon reflexes. Maintain skin integrity by protecting feet from breakdown. Advice patient who smokes to stop smoking or reduce if possible, to reduce vasoconstriction and enhance peripheral flow.